Yervoy 50 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21VR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,039
Award facts
- Contract value 100% obligated
- $25,038.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Yervoy (ipilimumab) 50 mg/10 mL vials with a ceiling value of $25,038.88. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 26, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 vehicle that extends through December 31, 2031, and serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting global military healthcare operations.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor within the federal medical procurement system, supplying a diverse portfolio of brand-name and generic medications, vaccines, and medical devices to military and veteran healthcare systems. Yervoy is an immunotherapy medication used in cancer treatment, consistent with AmerisourceBergen's demonstrated capability to deliver specialized pharmaceutical products across multiple therapeutic domains. The company's performance under its DLA IDC demonstrates its efficiency in fulfilling essential pharmaceutical requirements for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F21VR?
SPE2DR26F21VR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F21VR worth?
The government has obligated $25,039 on SPE2DR26F21VR.
Is contract SPE2DR26F21VR an order under another contract?
Yes. SPE2DR26F21VR is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21VR competed?
The extent of competition for SPE2DR26F21VR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award